Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment
Xing Huang, Gang Zhang, Tianyu Tang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188696-188696
Closed Access | Times Cited: 19

Showing 19 citing articles:

Role of NEK2 in tumorigenesis and tumor progression
Jiliang Xia, Hongyan Zhao, Jacob L Edmondson, et al.
Trends in Molecular Medicine (2024)
Open Access | Times Cited: 8
Regulation of post-translational modification of PD-L1 and advances in tumor immunotherapy
Chong Feng, Lening Zhang, Xin Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
NEK2 inactivates the Hippo pathway to advance the proliferation of cervical cancer cells by cooperating with STRIPAK complexes
Yanru Zhang, Peng‐Sheng Zheng
Cancer Letters (2022) Vol. 549, pp. 215917-215917
Open Access | Times Cited: 20
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle
Haoyu Zhou, Yichang Wang, Tuo Wang, et al.
Oncology Letters (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 4
Targeting NEK Kinases in Gastrointestinal Cancers: Insights into Gene Expression, Function, and Inhibitors
Lei Chen, Heng Lu, Farah Ballout, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1992-1992
Open Access
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
NEK2 promotes cancer cell progression and 5-fluorouracil resistance via the Wnt/β-catenin signaling pathway in colorectal cancer
Facai Cui, Yu Chen, Xiaoyu Wu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Four‐gene Prognostic Signature and Risk of Brain Metastasis of Lung Adenocarcinoma
Zheng Gong, Fengyuan Yu, Chen Li, et al.
Molecular Carcinogenesis (2025)
Open Access
NEK2 promotes the migration and proliferation of ESCC via stabilization of YAP1 by phosphorylation at Thr-143
Wei Su, Hao Hu, Qiurong Ding, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 18
NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway
Dong Guo, Weinan Yao, Xingyu Du, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway
J. Li, Yaojie Wang, Sisi Wei, et al.
Molecular Carcinogenesis (2024)
Open Access | Times Cited: 2
Primary cilia: Structure, dynamics, and roles in cancer cells and tumor microenvironment
Yiting Guan, Chong Zhang, Hongyong Zhang, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 8, pp. 1788-1807
Open Access | Times Cited: 6
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment
Domiziana Masci, Chiara Naro, Michela Puxeddu, et al.
Molecules (2023) Vol. 28, Iss. 22, pp. 7513-7513
Open Access | Times Cited: 6
Differential Expression of NEK Kinase Family Members in Esophageal Adenocarcinoma and Barrett’s Esophagus
Lei Chen, Farah Ballout, Heng Lu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4821-4821
Open Access | Times Cited: 4
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Lanyue Zhang, Yang Li, Juexiao Deng, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
Tailiang Lu, Chenglong Li, Yongqiang Gong, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 10, pp. 1717-1738
Open Access | Times Cited: 2
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Lanyue Zhang, Yang Li, Wenxin Liao, et al.
Research Square (Research Square) (2024)
Open Access
Effects of targeting highly expressed in cancer protein 1 (Hec1) inhibitor INH 1 in breast cancer cell lines In Vitro
Mehmet Topçul, İdi̇l Çeti̇n
Cellular and Molecular Biology (2023) Vol. 69, Iss. 14, pp. 109-113
Open Access | Times Cited: 1
(Benz)imidazoles
Junli Huang, Jianjun Chen
Elsevier eBooks (2023), pp. 227-256
Closed Access
Page 1

Scroll to top